Use of Nanocarriers for Transdermal Vaccine Delivery

Transdermal delivery is a safe, noninvasive method of administering vaccines directly onto bare skin, offering several potential advantages over traditional needle delivery. This technology is limited by the relative inefficiency of transport of large‐molecular‐weight vaccine antigens across intact...

Full description

Saved in:
Bibliographic Details
Published in:Clinical pharmacology and therapeutics 2007-12, Vol.82 (6), p.641-643
Main Authors: Lawson, L B, Freytag, L C, Clements, J D
Format: Article
Language:English
Subjects:
Administration, Cutaneous
Animals
Biological and medical sciences
Humans
Macromolecular Substances - administration & dosage
Medical sciences
Nanocapsules
Nanotechnology
Pharmacology. Drug treatments
Skin Absorption
Vaccines - administration & dosage
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3735-10e7effbfbb2ac91168fa77052dad68563e928fa10d4b48714e9fe42805c77b53
cites cdi_FETCH-LOGICAL-c3735-10e7effbfbb2ac91168fa77052dad68563e928fa10d4b48714e9fe42805c77b53
container_end_page 643
container_issue 6
container_start_page 641
container_title Clinical pharmacology and therapeutics
container_volume 82
creator Lawson, L B
Freytag, L C
Clements, J D
description Transdermal delivery is a safe, noninvasive method of administering vaccines directly onto bare skin, offering several potential advantages over traditional needle delivery. This technology is limited by the relative inefficiency of transport of large‐molecular‐weight vaccine antigens across intact skin. Recent evidence has shown that this barrier can be overcome by properly structured nanosized particles (nanocarriers). The specialized assembly of each type of nanocarrier gives each unique properties and different interactions within the stratum corneum. The use of nanocarriers for vaccine delivery is a platform technology, applicable to delivery of a variety of existing and potential vaccines. Clinical Pharmacology & Therapeutics (2007) 82, 641–643. doi:10.1038/sj.clpt.6100425
doi_str_mv 10.1038/sj.clpt.6100425
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68498898</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68498898</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3735-10e7effbfbb2ac91168fa77052dad68563e928fa10d4b48714e9fe42805c77b53</originalsourceid><addsrcrecordid>eNqFkDtPwzAURi0EoqUws6EssKW14_g1ovKUKmBoWS3HuZZS5VHsFtR_j6MGdWSybB1_370HoWuCpwRTOQvrqa032yknGOcZO0FjwmiWckbZKRpjjFWqMspH6CKEdbzmSspzNCJCKakIGaN8FSDpXPJm2s4a7yvwIXGdT5betKEE35g6-TTWVi0kD1BX3-D3l-jMmTrA1XBO0OrpcTl_SRfvz6_z-0VqqaAsJRgEOFe4osiMjXVcOiMEZllpSi4Zp6Cy-ERwmRe5FCQH5SDPJGZWiILRCbo75G5897WDsNVNFSzUtWmh2wXNZb-PkhGcHUDruxA8OL3xVWP8XhOse1E6rHUvSg-i4o-bIXpXNFAe-cFMBG4HwARrahd12CocuVjMOe6rxYH7qWrY_9er5x_LvxF-AYa9go4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68498898</pqid></control><display><type>article</type><title>Use of Nanocarriers for Transdermal Vaccine Delivery</title><source>Wiley</source><creator>Lawson, L B ; Freytag, L C ; Clements, J D</creator><creatorcontrib>Lawson, L B ; Freytag, L C ; Clements, J D</creatorcontrib><description>Transdermal delivery is a safe, noninvasive method of administering vaccines directly onto bare skin, offering several potential advantages over traditional needle delivery. This technology is limited by the relative inefficiency of transport of large‐molecular‐weight vaccine antigens across intact skin. Recent evidence has shown that this barrier can be overcome by properly structured nanosized particles (nanocarriers). The specialized assembly of each type of nanocarrier gives each unique properties and different interactions within the stratum corneum. The use of nanocarriers for vaccine delivery is a platform technology, applicable to delivery of a variety of existing and potential vaccines. Clinical Pharmacology &amp; Therapeutics (2007) 82, 641–643. doi:10.1038/sj.clpt.6100425</description><identifier>ISSN: 0009-9236</identifier><identifier>EISSN: 1532-6535</identifier><identifier>DOI: 10.1038/sj.clpt.6100425</identifier><identifier>PMID: 17998911</identifier><identifier>CODEN: CLPTAT</identifier><language>eng</language><publisher>New York, NY: Nature Publishing</publisher><subject>Administration, Cutaneous ; Animals ; Biological and medical sciences ; Humans ; Macromolecular Substances - administration &amp; dosage ; Medical sciences ; Nanocapsules ; Nanotechnology ; Pharmacology. Drug treatments ; Skin Absorption ; Vaccines - administration &amp; dosage</subject><ispartof>Clinical pharmacology and therapeutics, 2007-12, Vol.82 (6), p.641-643</ispartof><rights>2007 American Society for Clinical Pharmacology and Therapeutics</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3735-10e7effbfbb2ac91168fa77052dad68563e928fa10d4b48714e9fe42805c77b53</citedby><cites>FETCH-LOGICAL-c3735-10e7effbfbb2ac91168fa77052dad68563e928fa10d4b48714e9fe42805c77b53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19886608$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17998911$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lawson, L B</creatorcontrib><creatorcontrib>Freytag, L C</creatorcontrib><creatorcontrib>Clements, J D</creatorcontrib><title>Use of Nanocarriers for Transdermal Vaccine Delivery</title><title>Clinical pharmacology and therapeutics</title><addtitle>Clin Pharmacol Ther</addtitle><description>Transdermal delivery is a safe, noninvasive method of administering vaccines directly onto bare skin, offering several potential advantages over traditional needle delivery. This technology is limited by the relative inefficiency of transport of large‐molecular‐weight vaccine antigens across intact skin. Recent evidence has shown that this barrier can be overcome by properly structured nanosized particles (nanocarriers). The specialized assembly of each type of nanocarrier gives each unique properties and different interactions within the stratum corneum. The use of nanocarriers for vaccine delivery is a platform technology, applicable to delivery of a variety of existing and potential vaccines. Clinical Pharmacology &amp; Therapeutics (2007) 82, 641–643. doi:10.1038/sj.clpt.6100425</description><subject>Administration, Cutaneous</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Humans</subject><subject>Macromolecular Substances - administration &amp; dosage</subject><subject>Medical sciences</subject><subject>Nanocapsules</subject><subject>Nanotechnology</subject><subject>Pharmacology. Drug treatments</subject><subject>Skin Absorption</subject><subject>Vaccines - administration &amp; dosage</subject><issn>0009-9236</issn><issn>1532-6535</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqFkDtPwzAURi0EoqUws6EssKW14_g1ovKUKmBoWS3HuZZS5VHsFtR_j6MGdWSybB1_370HoWuCpwRTOQvrqa032yknGOcZO0FjwmiWckbZKRpjjFWqMspH6CKEdbzmSspzNCJCKakIGaN8FSDpXPJm2s4a7yvwIXGdT5betKEE35g6-TTWVi0kD1BX3-D3l-jMmTrA1XBO0OrpcTl_SRfvz6_z-0VqqaAsJRgEOFe4osiMjXVcOiMEZllpSi4Zp6Cy-ERwmRe5FCQH5SDPJGZWiILRCbo75G5897WDsNVNFSzUtWmh2wXNZb-PkhGcHUDruxA8OL3xVWP8XhOse1E6rHUvSg-i4o-bIXpXNFAe-cFMBG4HwARrahd12CocuVjMOe6rxYH7qWrY_9er5x_LvxF-AYa9go4</recordid><startdate>200712</startdate><enddate>200712</enddate><creator>Lawson, L B</creator><creator>Freytag, L C</creator><creator>Clements, J D</creator><general>Nature Publishing</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200712</creationdate><title>Use of Nanocarriers for Transdermal Vaccine Delivery</title><author>Lawson, L B ; Freytag, L C ; Clements, J D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3735-10e7effbfbb2ac91168fa77052dad68563e928fa10d4b48714e9fe42805c77b53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Administration, Cutaneous</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Humans</topic><topic>Macromolecular Substances - administration &amp; dosage</topic><topic>Medical sciences</topic><topic>Nanocapsules</topic><topic>Nanotechnology</topic><topic>Pharmacology. Drug treatments</topic><topic>Skin Absorption</topic><topic>Vaccines - administration &amp; dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lawson, L B</creatorcontrib><creatorcontrib>Freytag, L C</creatorcontrib><creatorcontrib>Clements, J D</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical pharmacology and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lawson, L B</au><au>Freytag, L C</au><au>Clements, J D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Use of Nanocarriers for Transdermal Vaccine Delivery</atitle><jtitle>Clinical pharmacology and therapeutics</jtitle><addtitle>Clin Pharmacol Ther</addtitle><date>2007-12</date><risdate>2007</risdate><volume>82</volume><issue>6</issue><spage>641</spage><epage>643</epage><pages>641-643</pages><issn>0009-9236</issn><eissn>1532-6535</eissn><coden>CLPTAT</coden><abstract>Transdermal delivery is a safe, noninvasive method of administering vaccines directly onto bare skin, offering several potential advantages over traditional needle delivery. This technology is limited by the relative inefficiency of transport of large‐molecular‐weight vaccine antigens across intact skin. Recent evidence has shown that this barrier can be overcome by properly structured nanosized particles (nanocarriers). The specialized assembly of each type of nanocarrier gives each unique properties and different interactions within the stratum corneum. The use of nanocarriers for vaccine delivery is a platform technology, applicable to delivery of a variety of existing and potential vaccines. Clinical Pharmacology &amp; Therapeutics (2007) 82, 641–643. doi:10.1038/sj.clpt.6100425</abstract><cop>New York, NY</cop><pub>Nature Publishing</pub><pmid>17998911</pmid><doi>10.1038/sj.clpt.6100425</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0009-9236
ispartof Clinical pharmacology and therapeutics, 2007-12, Vol.82 (6), p.641-643
issn 0009-9236
1532-6535
language eng
recordid cdi_proquest_miscellaneous_68498898
source Wiley
subjects Administration, Cutaneous
Animals
Biological and medical sciences
Humans
Macromolecular Substances - administration & dosage
Medical sciences
Nanocapsules
Nanotechnology
Pharmacology. Drug treatments
Skin Absorption
Vaccines - administration & dosage
title Use of Nanocarriers for Transdermal Vaccine Delivery
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T22%3A02%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Use%20of%20Nanocarriers%20for%20Transdermal%20Vaccine%20Delivery&rft.jtitle=Clinical%20pharmacology%20and%20therapeutics&rft.au=Lawson,%20L%20B&rft.date=2007-12&rft.volume=82&rft.issue=6&rft.spage=641&rft.epage=643&rft.pages=641-643&rft.issn=0009-9236&rft.eissn=1532-6535&rft.coden=CLPTAT&rft_id=info:doi/10.1038/sj.clpt.6100425&rft_dat=%3Cproquest_cross%3E68498898%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3735-10e7effbfbb2ac91168fa77052dad68563e928fa10d4b48714e9fe42805c77b53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=68498898&rft_id=info:pmid/17998911&rfr_iscdi=true